Green Bay, Wisconsin - Pharmacy Stars, a leading advocate for pharmaceutical quality and safety, proudly announces a groundbreaking live book discussion featuring a renowned industry expert, Martin VanTrieste, President and Chief Executive Officer, Civica Inc. The event, scheduled for November 29th, aims to highlight crucial issues highlighted in a recent FDA report on drug shortages and the enduring solutions proposed.
The FDA's report identifies one of the key causes of drug shortages as a lack of recognition and reward for manufacturers with "mature quality systems."Protecting Patients at All Costs: The Drug Watch Dogs," delves into the challenges of the pharmaceutical industry and proposes strategies for continuous improvement and early detection of supply chain issues.
VanTrieste, a seasoned pharmaceutical quality professional and trained pharmacist, has dedicated significant time and effort to share his insights in this book. "Writing a book was the hardest thing I have ever done. I spent 8 to 10 hours a day for 3 months writing my book," VanTrieste shared. The inspiration for his book arose from a health scare that led to an unexpected discovery of kidney cancer, providing him with a unique perspective on the pharmaceutical industry's challenges and the critical role of quality assurance.
Pharmacy Stars is delighted to facilitate this enlightening discussion as part of its commitment to advancing pharmaceutical quality and safety. VanTrieste's message underscores the importance of quality assurance processes in health system pharmacies, aligning with the USP standards for compounded sterile preparations. The live book discussion aims to inspire health system pharmacy leaders, who rely on pharmaceutical manufacturers for drug supplies and adhere to stringent quality control processes.
"We are delighted to be able to provide copies of his book and sponsor his book talk", remarked Keith Streckenbach, CEO of Pharmacy Stars. He went on to say, “The fact that Martin is not only a seasoned and well-regarded pharmaceutical quality professional, but also the founder of CivicaRx, and a trained pharmacist, makes his book such a perfect read for health system pharmacy leaders."
In the face of evolving challenges in sterile compounding and drug shortages, Pharmacy Stars advocates for a proactive approach. VanTriesteTrieste's book shares his experiences and aligns with the FDA's suggestion of developing a rating system to incentivize manufacturers toward investing in quality management maturity for their facilities.
About Martin VanTrieste
Martin is the President Emeritus of and previously the founder and first CEO of Civica Rx, a non-profit U.S. pharmaceutical company where he was instrumental in designing the business model for the organization and works pro-bono. ModernHealthcare recently named Martin as a top 100 industry influencer. Medicine Maker has recognized him as a “Champion of Change” on their Power List for his role in leading Civica, which was created to stabilize the supply of essential generic medications. Martin brings over 36 years in the industry, with comprehensive experience in biopharmaceutical manufacturing, quality systems, and related government regulations in the US and worldwide.
He was the former chief quality officer at Amgen. Before joining Amgen, Mr. VanTrieste was with Bayer Healthcare’s Biological Products Division as vice president of worldwide quality and Abbott Laboratories as the vice president of quality assurance for the Hospital Products Division. Mr. VanTrieste is the founder of Rx-360, an international nonprofit organization that enhances patient safety by increasing security and quality in the biopharmaceutical supply chain. He has also served as the Chairman and Board Member of the Parenteral Drug Association (PDA) Board of Directors. The PDA has 10,000 members, and its mission is to advance pharmaceutical/biopharmaceutical manufacturing science and regulation so members can better serve patients. PharmaVoice has named Mr. VanTrieste one of the 100 most inspiring people in the pharmaceutical industry, calling him “a man with a mission.” The Medicine Maker has previously named him one of the most influential people in the world of drug development and manufacture, saying he “is known throughout the industry as a change agent and influencer for his work on advancing pharmaceutical manufacturing, quality and helping to ensure a more reliable supply of high-quality medicines.” He was honored in 2013 by Parenteral Drug Association (PDA), naming an annual award the Martin VanTrieste Pharmaceutical Science Award. He has delivered numerous presentations and authored articles on pharmaceutical quality and the supply chain’s security and robustness. Serving Patients is our Privilege. Mr. VanTrieste earned a Pharmacy degree in 1983 from Temple University School of Pharmacy.
About Pharmacy Stars
Serving over 1,400 hospitals in the United States and Canada, Compounding360, is the #1 enterprise compounding quality management system, that gets work done in a fraction of the time it takes with legacy IV documentation tools or paper and Excel. Compound360 aims to standardize and centrally control compounding compliance across large-scale health systems.